Highlights
NYSE: AXON       Axon Enterprise Inc
Last Price Today's Change   Day's Range   Trading Volume
143.04   -0.74 (0.51%)  128.01 - 155.36  911,200

Overview

 
Avg Volume (4 weeks):827,221
4 Weeks Range:128.01 - 212.37
4 Weeks Price Volatility (%):
17.82%
52 Weeks Range:128.01 - 212.37
52 Weeks Price Volatility (%):
17.82%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Axovant Sciences Ltd. is a clinical-stage biopharmaceutical company. The Company is focused on acquiring, developing and commercializing therapeutics for the treatment of dementia, including Alzheimer's disease and Lewy body dementia. The Company intends to develop a pipeline of product candidates to address the cognitive, functional and behavioral aspects of dementia and related neurological disorders. The Company is focused to develop its lead product candidate, intepirdine, a selective 5-hydroxytryptamine 6 receptor antagonist, for the treatment of Alzheimer's disease and dementia with Lewy bodies (DLB). The Company also focuses on developing nelotanserin, a selective 5-hydroxytryptamine 2A receptor inverse agonist, for the treatment of rapid eye movement (REM) behavior disorder (RBD) in DLB patients, and visual hallucinations in patients with Lewy body dementia. The Company's pipeline also includes RVT-103 and RVT-104.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

5985  3514  428  81 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 EYES 5.79+3.50 
 SNDL 1.13-0.05 
 SQQQ 15.04-0.30 
 NIO 38.11-1.13 
 PLTR 23.95-0.41 
 UVXY 8.72-0.46 
 AAPL 121.42+0.44 
 SPY 383.63+3.17 
 BCS 9.55-0.09 
 CTRM 0.807+0.017